Kardigan, Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Kardigan, Inc.
RECRUITINGPhase 2 / Phase 3NCT07210723
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated...
The Sponsor is studying an investigational medication called danicamtiv to determine if it can help people with genetic and familial dilated cardiomyopathy (DCM). Investigational...
Sponsor: Kardigan, Inc.Enrolling: 33220 locations
Symptomatic Genetic Dilated Cardiomyopathy
RECRUITINGPhase 2 / Phase 3NCT07001800
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
The purpose of this study is to evaluate if ataciguat slows the progression of moderate calcific aortic valve stenosis in adults.
Sponsor: Kardigan, Inc.Enrolling: 127620 locations
Moderate Aortic Valve Stenosis